New app aims to ease chemo side effects for cancer patients

NCT ID NCT07218874

Completed Symptom relief Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 08, 2026 · Updated 3 times

Summary

This study is testing whether a mobile app that combines daily symptom reports with Fitbit data can help cancer patients better manage side effects during chemotherapy. Fifty adults with solid tumors will use the app for 90 days, receiving tips for mild symptoms and alerts to contact their doctor for more serious ones. The goal is to see if the app is easy to use and improves quality of life and communication with the care team.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mobile Symptom Monitoring and Alert App
What this could lead to: If successful, this app could help cancer patients better manage chemotherapy side effects and improve communication with their care team.
What could go wrong: This is a small, early feasibility study with only 50 participants, so results may not apply to all patients. The app is a monitoring tool, not a treatment, so it won't directly affect the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CHEMOTHERAPY SOLID TUMOR CANCER

Contacts and locations

Locations

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.